Despite some similar signaling pathways, NOD1 and NOD2 can produce divergent metabolic and immunometabolism outcomes, including regulation of blood glucose and adipose tissue inflammation during obesity.20 The gene discussed is NOD1; the disease is obesity due to melanocortin 4 receptor deficiency.